AstraZeneca-Merck drug Lynparza approved for two cancers by EU agency.
THD NewsDesk (Reuters): On Monday, The European Medicines Agency (EMA) has approved for Lynparza in patients with a sort of ...
THD NewsDesk (Reuters): On Monday, The European Medicines Agency (EMA) has approved for Lynparza in patients with a sort of ...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily